Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Neural compensation in people with Alzheimer's-related protein

  • Measuring modified protein structures: New approach

  • Identifying a better message strategy for dissuading smokers: Add the positive

  • Concept of time may predict impulsive behavior, research finds

  • Web based training can reduce campus rape, study concludes

  • Exxon Valdez 2014: Does media coverage of humanmade disasters contribute to consumer complacency?

  • We see art more as a person than an object: 'Magical contagion' spreads creator's essence to pieces

  • Do ads showing sexy women make male consumers less charitable?

  • Do you always get what you pay for? How consumers mispredict product quality

  • Why are consumers willing to spend more money on ethical products?

  •